Step 8 of 10 · Decision support
Treatment plan
What this step shows
The recommended next treatment step, following statin → ezetimibe → PCSK9 inhibitor and taking intolerance and time on therapy into account.
Clinical pathway
Secondary Prevention
Risk category
Very High
LDL-C target
<1.4 mmol/L
Recommended next step
Initiate high-intensity statin
No lipid-lowering therapy on file yet and no intolerance recorded — start with a high-intensity statin.
Current therapy on record
No statin + ezetimibe · 12 month(s) on this regimen
Edit
How this was decided
- ✕ LDL-C already at target? 14 mmol/L vs. target <1.4 mmol/L.
- ✕ Currently on a statin? No statin.